https://www.prognyx.com/blog/fda-approves-atezolizumab-plus-chemo-for-adjuvant-stage-iii-dmmr-colon-cancerPrognyxen2026-10-09FDA approves atezolizumab plus chemo for adjuvant Stage III dMMR colon cancer https://www.prognyx.com/blog/fda-approves-pfizer-s-tucatinib-triplet-for-her2-positive-breast-cancer-maintenaPrognyxen2026-10-08FDA approves Pfizer's tucatinib triplet for HER2-positive breast cancer maintenance